Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 114.99 USD -0.24% Market Closed
Market Cap: 199.4B USD
Have any thoughts about
Abbott Laboratories?
Write Note
Section:
 

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 123.87 USD. Compared to the current market price of 114.99 USD, Abbott Laboratories is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABT Relative Value
Base Case
123.87 USD
Undervaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.8
P/S
P/S
Price to Sales
4.8
vs History
38
vs Industry
29
Median 3Y
4.6
Median 5Y
4.7
Industry
2.3
Forward
4.7
More Details
34.6
P/E
P/E
Price to Earnings
34.6
vs History
42
vs Industry
17
Median 3Y
32
Median 5Y
34.4
Industry
23.2
Forward
24.3
More Details
22.9
P/OCF
P/OCF
Price to OCF
22.9
vs History
50
vs Industry
16
Median 3Y
22.6
Median 5Y
23
Industry
14.3
More Details
35.5
P/FCFE
P/FCFE
Price to FCFE
35.5
vs History
44
vs Industry
8
Median 3Y
30.5
Median 5Y
34.4
Industry
20.1
More Details
5
P/B
P/B
Price to Book Value
5
vs History
60
vs Industry
18
Median 3Y
5.1
Median 5Y
5.2
Industry
2.2
More Details
5
EV/S
EV/S
Enterprise Value to Sales
5
vs History
44
vs Industry
26
Median 3Y
4.7
Median 5Y
4.9
Industry
2.4
Forward
4.8
More Details
8.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.9
vs History
42
vs Industry
26
Median 3Y
8.6
Median 5Y
8.8
Industry
5
More Details
20.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.1
vs History
44
vs Industry
18
Median 3Y
18.7
Median 5Y
19.8
Industry
12.8
Forward
18.8
More Details
29.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29.4
vs History
46
vs Industry
15
Median 3Y
27.8
Median 5Y
29.3
Industry
17.2
Forward
21.7
More Details
23.4
EV/OCF
EV/OCF
Enterprise Value to OCF
23.4
vs History
50
vs Industry
15
Median 3Y
23.1
Median 5Y
23.6
Industry
14
More Details
31.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
31.5
vs History
52
vs Industry
12
Median 3Y
29.1
Median 5Y
32.5
Industry
18.2
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
36
vs Industry
27
Median 3Y
3.3
Median 5Y
3.2
Industry
1.9
More Details

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
NYSE:ABT
199.4B USD 4.8 34.6 20.1 29.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.5B USD 24.2 84.9 72.5 90
US
Stryker Corp
NYSE:SYK
139.9B USD 6.4 39 25.3 30.8
US
Boston Scientific Corp
NYSE:BSX
133.6B USD 8.4 74.5 34.2 48.8
IE
Medtronic PLC
NYSE:MDT
103.6B USD 3.1 24.1 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66B USD 3.3 38.3 15.8 28.3
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.6B USD 7.9 10.7 23.9 26.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
313.1B CNY 8.4 25.3 22 22
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.3B USD 1.9 21.7 13.6 16.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.2B USD 8.9 39.4 31.1 31.1

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.